Modification of Thiol Functionalized Aptamers by Conjugation of Synthetic Polymers

被引:37
作者
Da Pieve, Chiara [1 ]
Williams, Paul [2 ]
Haddleton, David M. [3 ]
Palmer, Richard M. J. [2 ]
Missailidis, Sotiris [1 ]
机构
[1] Open Univ, Dept Chem & Analyt Sci, Milton Keynes MK6 7AA, Bucks, England
[2] Warwick Effect Polymers Ltd, Coventry CV4 7EZ, W Midlands, England
[3] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England
关键词
LIVING RADICAL POLYMERIZATION; ATOM-TRANSFER POLYMERIZATION; POLYETHYLENE-GLYCOL; PEGYLATION; PROTEINS; THERAPY; DNA; PEGAPTANIB; DELIVERY; BIODISTRIBUTION;
D O I
10.1021/bc900397s
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Aptamers are known for their short in vivo circulating half-life and rapid renal clearance. Their conjugation to poly(ethylene glycol) (PEG) is a way to improve their residence in the body. Two Aptamers (AptD and AptF), having a disulfide protected thiol modification oil the 3' end, have been conjugated to maleimide activated PEGs of various molecular weights and structures (linear PEG20; branched PEG20 and 40 PolyPEG17, 40, and 60 kDa). The high yield Coupling (70-80% in most of the cases) could be achieved using immobilized Iris[2-carboxyethyl]phosphine, hydrochloride (TCEP) as reducing agent at pH 4, The affinity of PEGylated AptD for its target was reduced by Conjugation to linear PEG20 and branched PEG40, but not to branched PEG20 and PolyPEGs. This work demonstrates an alternative approach to PEGylation of Aptamers, and that the effect of PEG oil the affinity for the target varies according to the structure and conformation of the synthetic polymer.
引用
收藏
页码:169 / 174
页数:6
相关论文
共 42 条
[1]   Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals [J].
Adamis, AP ;
Altaweel, M ;
Bressler, NM ;
Cunningham, ET ;
Davis, MD ;
Goldbaum, M ;
Gonzales, C ;
Guyer, DR ;
Katz, B ;
Patel, M .
OPHTHALMOLOGY, 2006, 113 (01) :23-28
[2]   Polyethylene glycol-conjugated pharmaceutical proteins [J].
Bailon, P ;
Berthold, W .
PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1998, 1 (08) :352-356
[3]   Short communication: Renal tubular vacuolation in animals treated with polyethylene-glycol-conjugated proteins [J].
Bendele, A ;
Seely, J ;
Richey, C ;
Sennello, G ;
Shopp, G .
TOXICOLOGICAL SCIENCES, 1998, 42 (02) :152-157
[4]  
BRODY EN, 2000, MOL BIOTECHNOL, V74, P5
[5]  
Conover CD, 1997, ARTIF ORGANS, V21, P1066
[6]   Anti-MUC1 aptamers: radiolabelling with 99mTc and biodistribution in MCF-7 tumour-bearing mice [J].
Da Pieve, Chiara ;
Perkins, Alan C. ;
Missailidis, Sotiris .
NUCLEAR MEDICINE AND BIOLOGY, 2009, 36 (06) :703-710
[7]   SIMULTANEOUS ANALYSIS OF FAMILIES OF SIGMOIDAL CURVES - APPLICATION TO BIOASSAY, RADIOLIGAND ASSAY, AND PHYSIOLOGICAL DOSE-RESPONSE CURVES [J].
DELEAN, A ;
MUNSON, PJ ;
RODBARD, D .
AMERICAN JOURNAL OF PHYSIOLOGY, 1978, 235 (02) :E97-E102
[8]   The dawning era of polymer therapeutics [J].
Duncan, R .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (05) :347-360
[9]   DNA aptamers that bind to MUC1 tumour marker: Design and characterization of MUC1-binding single-stranded DNA aptamers [J].
Ferreira, C. S. M. ;
Matthews, C. S. ;
Missailidis, S. .
TUMOR BIOLOGY, 2006, 27 (06) :289-301
[10]   Novel approach to specific growth factor inhibition in vivo -: Antagonism of platelet-derived growth factor in glomerulonephritis by aptamers [J].
Floege, J ;
Ostendorf, T ;
Janssen, U ;
Burg, M ;
Radeke, HH ;
Vargeese, C ;
Gill, SC ;
Green, LS ;
Janjic, N .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (01) :169-179